Nifar en es it fr

Nifar Brand names, Nifar Analogs

Nifar Brand Names Mixture

  • No information avaliable

Nifar Chemical_Formula


Nifar RX_link

Nifar fda sheet

Nifar FDA

Nifar msds (material safety sheet)

Nifar MSDS

Nifar Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Nifar Molecular Weight

346.335 g/mol

Nifar Melting Point

172 - 174 oC

Nifar H2O Solubility


Nifar State


Nifar LogP


Nifar Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Nifar Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Nifar Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Nifar Absorption

Rapidly and fully absorbed following oral administration.

Nifar side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Nifar Patient Information

Nifar Organisms Affected

Humans and other mammals